Exxon entered a 12-year agreement with Denmark’s Orsted A/S to buy 500 megawatts of wind and solar power in the Permian Basin, in-line with the company’s strategy to use renewable energy to produce oil in West Texas.
Although the terms of the contract are yet to be disclosed, according to Bloomberg NEF it is the largest ever renewable power contract signed by an oil company in the fastest growing U.S. oil field.
As per the company’s investor presentation, 50% of the power that Exxon will buy would come from the Sage Draw wind farm, which Orsted plans to get operational in 2020. The other 50% would come from the Permian Solar farm, scheduled to be operational in 2021.
Exxon, which has for some time now been criticized for downplaying the risks of climate change, has finally turned to clean energy as it also becomes cheaper. The company has been looking for renewable energy under long-term contracts since August, since the production boom in the region has grown so fast that infrastructure including pipelines and power plants have struggled to keep pace.
The 10-day RSI Oscillator for XOM moved out of overbought territory on April 12, 2024. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 45 instances where the indicator moved out of the overbought zone. In of the 45 cases the stock moved lower in the days that followed. This puts the odds of a move down at .
The Momentum Indicator moved below the 0 level on April 23, 2024. You may want to consider selling the stock, shorting the stock, or exploring put options on XOM as a result. In of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for XOM turned negative on April 15, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where XOM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
The 50-day moving average for XOM moved above the 200-day moving average on March 27, 2024. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where XOM advanced for three days, in of 322 cases, the price rose further within the following month. The odds of a continued upward trend are .
XOM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Aroon Indicator entered an Uptrend today. In of 266 cases where XOM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 70, placing this stock better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. XOM’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: XOM's P/B Ratio (2.267) is slightly higher than the industry average of (1.218). P/E Ratio (13.160) is within average values for comparable stocks, (24.146). Projected Growth (PEG Ratio) (6.848) is also within normal values, averaging (4.841). Dividend Yield (0.032) settles around the average of (0.107) among similar stocks. P/S Ratio (1.416) is also within normal values, averaging (0.979).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a distributer of crude oil, natural gas and petroleum products
Industry IntegratedOil